AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
Open Access
- 15 November 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (10), 1229-1240
- https://doi.org/10.1038/onc.2010.504
Abstract
Yes-associated protein (YAP) is a downstream effector of the Hippo signaling pathway, which controls organ expansion and tissue development. We have recently defined the tumorigenic potential and clinical significance of the YAP1 oncogene in human hepatocellular carcinoma (HCC). The present study aims to define the tumorigenic properties of YAP in HCC and elucidate the related downstream signaling mechanism. In a gain-of-function study, we demonstrated that ectopic increased expression of YAP in the immortalized non-tumorigenic hepatocyte cell line MIHA confers tumorigenic and metastatic potentials, as evidenced by (1) enhanced aptitudes in cell viability, anchorage-independent growth, migration and invasion; (2) tumor formation in a xenograft mouse model; and (3) induction of HCC biomarker α-fetoprotein and activation of mitogen-activated protein kinase. Furthermore, we have identified AXL, a receptor tyrosine kinase, as a key downstream target that drives YAP-dependent oncogenic functions. RNAi-mediated knockdown of AXL expression decreased the ability of YAP-expressing MIHA cells and of the primary HCC cell line to proliferate and invade. These results indicate that AXL is a mediator of YAP-dependent oncogenic activities and implicates it as a potential therapeutic target for HCC.Keywords
This publication has 46 references indexed in Scilit:
- Yorkie: the final destination of Hippo signalingTrends in Cell Biology, 2010
- Targeting YAP and Hippo signaling pathway in liver cancerEmerging Therapeutic Targets, 2010
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010
- Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaHepatology, 2009
- Yes‐associated protein is an independent prognostic marker in hepatocellular carcinomaCancer, 2009
- TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic TransformationPublished by Elsevier BV ,2009
- The Hippo–YAP pathway: new connections between regulation of organ size and cancerCurrent Opinion in Cell Biology, 2008
- Gas6 Anti-apoptotic Signaling Requires NF-κB ActivationPublished by Elsevier BV ,2001
- Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breastAnnals of Oncology, 2001
- Molecular classification of cutaneous malignant melanoma by gene expression profilingNature, 2000